2-tert-butylhydroquinone has been researched along with Genito-urinary Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, TW; Lau, SS; Monks, TJ; Peters, MM; Rivera, MI | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Genito-urinary Cancer
| Article | Year |
|---|---|
Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder.
Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Glutathione; Hydroquinones; Kidney; Male; Rats; Rats, Inbred F344; Urinary Bladder; Urogenital Neoplasms | 1996 |